Expression of multidrug-resistance-associated protein (MRP) and chemosensitivity in human gastric cancer

Kazuya Endo, Yoshihiko Maehara, Tetsuya Kusumoto, Yuji Ichiyoshi, Michihiko Kuwano, Keizo Sugimachi

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

Evidence has accumulated that, in addition to the MDR1 gene-coded P-glycoprotein (Pgp), multidrug resistance-associated protein (MRP) also mediates the multidrug resistance (MDR) of various human tumors. In the case of gastric cancer, there is little or no involvement of P-glycoprotein, and the mechanisms of MDR remain to be understood. To search for a possible relationship between expression of MRP and sensitivity to anti-cancer agents in gastric cancer, 4 gastric cancer cell lines, 43 human gastric carcinomas and 17 adjacent normal gastric tissue samples were analyzed. Expression of MRP mRNA was evaluated using reverse transcription PCR (RT-PCR) and Southern hybridization. Sensitivity of the test samples to the anti-cancer drugs cisplatin (CDDP), doxorubicin (DXR) and etoposide (VP-16) was examined using the MTT{3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl [2H]-tetrazolium bromide} assay. Immunohistochemical staining with the use of the MRP antibody (MRPr1) was done to confirm the findings regarding the expression of mRNA levels. The MRP expression evaluated with RT-PCR and Southern hybridization as well as with immunohistochemical staining revealed that 23 of 43 gastric-cancer tissues (53.5%), 15 of 17 normal gastric tissues (88%) and 3 of 4 gastric-cancer cell lines (75%) were positive. The MTT assay showed that DXR was significantly more sensitive (P < 0.01) in gastric carcinoma tissues lacking MRP expression than in those with positive expression. The same tendency was seen with the other agents used. Of the cell lines, one which showed no MRP expression also had a higher sensitivity to CDDP, DXR and VP-16 than the other positive cases. These results show that MRP expression is involved in MDR of human gastric cancer and is inversely related to the chemosensitivity of tumor cells against some anticancer drugs.

Original languageEnglish
Pages (from-to)372-377
Number of pages6
JournalInternational Journal of Cancer
Volume68
Issue number3
DOIs
Publication statusPublished - Nov 26 1996

Fingerprint

Multidrug Resistance-Associated Proteins
Stomach Neoplasms
Stomach
Multiple Drug Resistance
Etoposide
Doxorubicin
P-Glycoprotein
Cell Line
Reverse Transcription
Neoplasms
Staining and Labeling
Carcinoma
Polymerase Chain Reaction
Messenger RNA
Pharmaceutical Preparations
Cisplatin
Antibodies

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Expression of multidrug-resistance-associated protein (MRP) and chemosensitivity in human gastric cancer. / Endo, Kazuya; Maehara, Yoshihiko; Kusumoto, Tetsuya; Ichiyoshi, Yuji; Kuwano, Michihiko; Sugimachi, Keizo.

In: International Journal of Cancer, Vol. 68, No. 3, 26.11.1996, p. 372-377.

Research output: Contribution to journalArticle

Endo, Kazuya ; Maehara, Yoshihiko ; Kusumoto, Tetsuya ; Ichiyoshi, Yuji ; Kuwano, Michihiko ; Sugimachi, Keizo. / Expression of multidrug-resistance-associated protein (MRP) and chemosensitivity in human gastric cancer. In: International Journal of Cancer. 1996 ; Vol. 68, No. 3. pp. 372-377.
@article{cd6f809b2fdb4d12b0c3f8877a21a41f,
title = "Expression of multidrug-resistance-associated protein (MRP) and chemosensitivity in human gastric cancer",
abstract = "Evidence has accumulated that, in addition to the MDR1 gene-coded P-glycoprotein (Pgp), multidrug resistance-associated protein (MRP) also mediates the multidrug resistance (MDR) of various human tumors. In the case of gastric cancer, there is little or no involvement of P-glycoprotein, and the mechanisms of MDR remain to be understood. To search for a possible relationship between expression of MRP and sensitivity to anti-cancer agents in gastric cancer, 4 gastric cancer cell lines, 43 human gastric carcinomas and 17 adjacent normal gastric tissue samples were analyzed. Expression of MRP mRNA was evaluated using reverse transcription PCR (RT-PCR) and Southern hybridization. Sensitivity of the test samples to the anti-cancer drugs cisplatin (CDDP), doxorubicin (DXR) and etoposide (VP-16) was examined using the MTT{3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl [2H]-tetrazolium bromide} assay. Immunohistochemical staining with the use of the MRP antibody (MRPr1) was done to confirm the findings regarding the expression of mRNA levels. The MRP expression evaluated with RT-PCR and Southern hybridization as well as with immunohistochemical staining revealed that 23 of 43 gastric-cancer tissues (53.5{\%}), 15 of 17 normal gastric tissues (88{\%}) and 3 of 4 gastric-cancer cell lines (75{\%}) were positive. The MTT assay showed that DXR was significantly more sensitive (P < 0.01) in gastric carcinoma tissues lacking MRP expression than in those with positive expression. The same tendency was seen with the other agents used. Of the cell lines, one which showed no MRP expression also had a higher sensitivity to CDDP, DXR and VP-16 than the other positive cases. These results show that MRP expression is involved in MDR of human gastric cancer and is inversely related to the chemosensitivity of tumor cells against some anticancer drugs.",
author = "Kazuya Endo and Yoshihiko Maehara and Tetsuya Kusumoto and Yuji Ichiyoshi and Michihiko Kuwano and Keizo Sugimachi",
year = "1996",
month = "11",
day = "26",
doi = "10.1002/(SICI)1097-0215(19961104)68:3<372::AID-IJC16>3.0.CO;2-A",
language = "English",
volume = "68",
pages = "372--377",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Expression of multidrug-resistance-associated protein (MRP) and chemosensitivity in human gastric cancer

AU - Endo, Kazuya

AU - Maehara, Yoshihiko

AU - Kusumoto, Tetsuya

AU - Ichiyoshi, Yuji

AU - Kuwano, Michihiko

AU - Sugimachi, Keizo

PY - 1996/11/26

Y1 - 1996/11/26

N2 - Evidence has accumulated that, in addition to the MDR1 gene-coded P-glycoprotein (Pgp), multidrug resistance-associated protein (MRP) also mediates the multidrug resistance (MDR) of various human tumors. In the case of gastric cancer, there is little or no involvement of P-glycoprotein, and the mechanisms of MDR remain to be understood. To search for a possible relationship between expression of MRP and sensitivity to anti-cancer agents in gastric cancer, 4 gastric cancer cell lines, 43 human gastric carcinomas and 17 adjacent normal gastric tissue samples were analyzed. Expression of MRP mRNA was evaluated using reverse transcription PCR (RT-PCR) and Southern hybridization. Sensitivity of the test samples to the anti-cancer drugs cisplatin (CDDP), doxorubicin (DXR) and etoposide (VP-16) was examined using the MTT{3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl [2H]-tetrazolium bromide} assay. Immunohistochemical staining with the use of the MRP antibody (MRPr1) was done to confirm the findings regarding the expression of mRNA levels. The MRP expression evaluated with RT-PCR and Southern hybridization as well as with immunohistochemical staining revealed that 23 of 43 gastric-cancer tissues (53.5%), 15 of 17 normal gastric tissues (88%) and 3 of 4 gastric-cancer cell lines (75%) were positive. The MTT assay showed that DXR was significantly more sensitive (P < 0.01) in gastric carcinoma tissues lacking MRP expression than in those with positive expression. The same tendency was seen with the other agents used. Of the cell lines, one which showed no MRP expression also had a higher sensitivity to CDDP, DXR and VP-16 than the other positive cases. These results show that MRP expression is involved in MDR of human gastric cancer and is inversely related to the chemosensitivity of tumor cells against some anticancer drugs.

AB - Evidence has accumulated that, in addition to the MDR1 gene-coded P-glycoprotein (Pgp), multidrug resistance-associated protein (MRP) also mediates the multidrug resistance (MDR) of various human tumors. In the case of gastric cancer, there is little or no involvement of P-glycoprotein, and the mechanisms of MDR remain to be understood. To search for a possible relationship between expression of MRP and sensitivity to anti-cancer agents in gastric cancer, 4 gastric cancer cell lines, 43 human gastric carcinomas and 17 adjacent normal gastric tissue samples were analyzed. Expression of MRP mRNA was evaluated using reverse transcription PCR (RT-PCR) and Southern hybridization. Sensitivity of the test samples to the anti-cancer drugs cisplatin (CDDP), doxorubicin (DXR) and etoposide (VP-16) was examined using the MTT{3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl [2H]-tetrazolium bromide} assay. Immunohistochemical staining with the use of the MRP antibody (MRPr1) was done to confirm the findings regarding the expression of mRNA levels. The MRP expression evaluated with RT-PCR and Southern hybridization as well as with immunohistochemical staining revealed that 23 of 43 gastric-cancer tissues (53.5%), 15 of 17 normal gastric tissues (88%) and 3 of 4 gastric-cancer cell lines (75%) were positive. The MTT assay showed that DXR was significantly more sensitive (P < 0.01) in gastric carcinoma tissues lacking MRP expression than in those with positive expression. The same tendency was seen with the other agents used. Of the cell lines, one which showed no MRP expression also had a higher sensitivity to CDDP, DXR and VP-16 than the other positive cases. These results show that MRP expression is involved in MDR of human gastric cancer and is inversely related to the chemosensitivity of tumor cells against some anticancer drugs.

UR - http://www.scopus.com/inward/record.url?scp=0029806169&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029806169&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1097-0215(19961104)68:3<372::AID-IJC16>3.0.CO;2-A

DO - 10.1002/(SICI)1097-0215(19961104)68:3<372::AID-IJC16>3.0.CO;2-A

M3 - Article

C2 - 8903480

AN - SCOPUS:0029806169

VL - 68

SP - 372

EP - 377

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 3

ER -